{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "professor of building physics and the environment",
    "Medical Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania, USA",
    "The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, USA",
    "6Iovance Biotherapeutics Inc., San Carlos, CA, USA",
    "Obsidian Therapeutics, Cambridge, MA, USA",
    "2Obsidian Therapeutics, Cambridge, MA, USA",
    "Stanford University School of Medicine, Stanford, California, USA",
    "Memorial Sloan Kettering Cancer Center, New York City, NY, USA",
    "Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia",
    "USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA",
    "James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA",
    "The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
    "Orlando Health Cancer Institute, Orlando, FL, USA",
    "JMQ Oncology Advisors LLC, Houston, TX, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 18,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Michael Davies"
    },
    {
      "affs": [
        1
      ],
      "name": "Yazan Samhouri"
    },
    {
      "affs": [
        2
      ],
      "name": "Omid Hamid"
    },
    {
      "affs": [
        3
      ],
      "name": "Giri Sulur"
    },
    {
      "affs": [
        4
      ],
      "name": "Raina Duan"
    },
    {
      "affs": [
        5
      ],
      "name": "Giridharan Ramsingh"
    },
    {
      "affs": [
        6
      ],
      "name": "Allison Betof"
    },
    {
      "affs": [
        7
      ],
      "name": "Alexander N Shoushtari"
    },
    {
      "affs": [
        8
      ],
      "name": "Georgina V Long"
    },
    {
      "affs": [
        9
      ],
      "name": "Gino K In"
    },
    {
      "affs": [
        10
      ],
      "name": "Jason A Chesney"
    },
    {
      "affs": [
        11
      ],
      "name": "Isabella C Glitza"
    },
    {
      "affs": [
        11
      ],
      "name": "Hussein A Tawbi"
    },
    {
      "affs": [
        11
      ],
      "name": "Rodabe N Amaria"
    },
    {
      "affs": [
        12
      ],
      "name": "Tirrell T Johnson"
    },
    {
      "affs": [
        13
      ],
      "name": "Jennifer L McQuade"
    },
    {
      "affs": [
        4
      ],
      "name": "Parameswaran N Hari"
    },
    {
      "affs": [
        4
      ],
      "name": "Ricky Rudraraju"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/8jjbm219ttw76.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0566",
  "fulltext_url": null,
  "id": "8jjbm219ttw76",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0566",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225326283",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A634.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-07",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/8jjbm219ttw76.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:12Z",
      "native_id": "283184550ee34c5ca48e3ef0b19078d9",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0566"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "566 OBX-115 TIL cell therapy in ICI-resistant advanced melanoma: pooled safety and updated efficacy with minimally invasive tumor tissue procurement, low-dose lymphodepletion, and IL2-free regimen",
  "title_text": "566 OBX-115 TIL cell therapy in ICI-resistant advanced melanoma: pooled safety and updated efficacy with minimally invasive tumor tissue procurement, low-dose lymphodepletion, and IL2-free regimen",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T14:20:59Z",
  "url": "https://research.draconitic.com/paper/8jjbm219ttw76",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}